Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
Recruiting · NCT07311993 · Registry updated 2026-10-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1 Study of CLR 125 in Triple Negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 1 | 2026-10-08 | NCT07311993 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cellectar Biosciences, Inc. | 5 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic Florida | Jacksonville | United States | 105 |
| Mayo Clinic Rochester | Rochester | United States | 133 |
| United Theranostics | Princeton | United States | 6 |
| United Theranostics | Glen Burnie | United States | 9 |